Dr. Patricia K. Coyle, Multiple Sclerosis Clinician And Researcher to Lecture on DMTs
Medicine, Health Care Dr. Patricia K. Coyle, Multiple…
Published: April 6, 2018.
Released by Consortium of MS Centers
Optimal use of disease-modifying therapies (DMTs) may be one of the single most important clinical decisions made in treating multiple sclerosis (MS). Currently, there are numerous DMT options and selection can be a complex issue for the clinician and patient. Patricia K. Coyle, MD, FAAN, FANA, Director, MS Comprehensive Care Center, Stony Brook University Medical Center, will present the Donald Paty Memorial Lecture at the CMSC Annual Meeting on “DMT-Debates – Stopping, Switching, Re-starting.” Her presentation will take place Saturday, June 2nd at 12 Noon, and is the closing lecture of the 2018 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) in Nashville, TN.
“There are many pros and cons to the various critical therapy decisions that we can make as clinicians. In my lecture I will cover induction versus escalation therapy, when to switch, and when it is reasonable to stop a DMT,” said Dr. Coyle. “My goal is for attendees to walk away with a good understanding on best DMT practices.”
Dr. Coyle is also Professor and Vice Chair (Clinical Affairs) of Neurology at Stony Brook University Medical Center in Stony Brook, NY. She received a BS degree with highest honors from Fordham University, and an MD degree from the Johns Hopkins University School of Medicine, where she was elected to Alpha Omega Alpha. While at the Johns Hopkins School of Medicine, she completed a residency and chief residency in neurology, followed by a two-year fellowship in neuroimmunology and neurovirology. Dr. Coyle is the author of numerous articles on clinical and basic research aspects of MS and neurologic infections. She is also a recognized expert on neurologic infections in addition to MS. Her areas of expertise include Lyme disease and neurologic infections, cerebrospinal fluid, therapeutics, and neuroimmunology.
Dr. Coyle is currently involved in a number of therapeutic trials testing new immunotherapies for MS, as well as studies addressing neurologic aspects of Lyme disease.
The CMSC Annual Meeting, May 30-June 2 at the Music City Center in Nashville, TN, is the largest educational conference and professional development event for all healthcare clinicians, researchers, scientists and professionals in training engaged in the MS field. The four-day educational program includes a full agenda of lectures, clinical courses, symposia, workshops, roundtables, panel discussions, posters and platform presentations.
Chinese French German Italian Japanese Korean Portuguese Russian Spanish